Supplementary Figure S15 from SPOP mutations target STING1 signaling in prostate cancer and create therapeutic vulnerabilities to PARP inhibitor–induced growth suppression Article Swipe
Related Concepts
PARP inhibitor
Prostate cancer
Poly ADP ribose polymerase
Cancer research
Cancer
Biology
Medicine
Internal medicine
Genetics
DNA
Polymerase
Chuandong Geng
,
Man-Chao Zhang
,
Ganiraju C. Manyam
,
Jody V. Vykoukal
,
Johannes F. Fahrmann
,
Shan Peng
,
Cheng Wu
,
Sanghee Park
,
Shakuntala Kondraganti
,
Daoqi Wang
,
Brian D. Robinson
,
Massimo Loda
,
Christopher E. Barbieri
,
Timothy A. Yap
,
Paul G. Corn
,
Samir Hanash
,
Bradley M. Broom
,
Patrick G. Pilié
,
Timothy C. Thompson
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.27034330.v1
· OA: W4402798164
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.27034330.v1
· OA: W4402798164
<p>Supplementary Fig. S15. Original unedited IB images for representative Western blots experiments (n-3) used in Figure 4D lower panels (RM-1-BM-EV/ inducible SPOPmuts)</p>
Related Topics
Finding more related topics…